BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 18162832)

  • 1. Intestinal permeability and effects of Lactobacillus rhamnosus therapy in children with short bowel syndrome.
    Sentongo TA; Cohran V; Korff S; Sullivan C; Iyer K; Zheng X
    J Pediatr Gastroenterol Nutr; 2008 Jan; 46(1):41-7. PubMed ID: 18162832
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immune response and intestinal permeability in children with acute gastroenteritis treated with Lactobacillus rhamnosus GG: a randomized, double-blind, placebo-controlled trial.
    Sindhu KN; Sowmyanarayanan TV; Paul A; Babji S; Ajjampur SS; Priyadarshini S; Sarkar R; Balasubramanian KA; Wanke CA; Ward HD; Kang G
    Clin Infect Dis; 2014 Apr; 58(8):1107-15. PubMed ID: 24501384
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Soluble Mediators From Lactobacillus rhamnosus Gorbach-Goldin Support Intestinal Barrier Function in Rats After Massive Small-Bowel Resection.
    Wu J; Yang K; Wu W; Tang Q; Zhong Y; Gross G; Lambers TT; van Tol EAF; Cai W
    JPEN J Parenter Enteral Nutr; 2018 Aug; 42(6):1026-1034. PubMed ID: 30133842
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Impact of Lactobacillus Probiotics on the Gut Microbiota in Children With Short Bowel Syndrome.
    Piper HG; Coughlin LA; Hussain S; Nguyen V; Channabasappa N; Koh AY
    J Surg Res; 2020 Jul; 251():112-118. PubMed ID: 32135381
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of the kinetics of intestinal colonization by associating 5 probiotic bacteria assumed either in a microencapsulated or in a traditional, uncoated form.
    Piano MD; Carmagnola S; Ballarè M; Balzarini M; Montino F; Pagliarulo M; Anderloni A; Orsello M; Tari R; Sforza F; Mogna L; Mogna G
    J Clin Gastroenterol; 2012 Oct; 46 Suppl():S85-92. PubMed ID: 22955366
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of probiotics in short bowel syndrome in infants and children--a systematic review.
    Reddy VS; Patole SK; Rao S
    Nutrients; 2013 Mar; 5(3):679-99. PubMed ID: 23462584
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Fecal Microbiome in Pediatric Patients With Short Bowel Syndrome.
    Davidovics ZH; Carter BA; Luna RA; Hollister EB; Shulman RJ; Versalovic J
    JPEN J Parenter Enteral Nutr; 2016 Nov; 40(8):1106-1113. PubMed ID: 26059898
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of Lactobacillus rhamnosus GG Administration on Vancomycin-Resistant Enterococcus Colonization in Adults with Comorbidities.
    Doron S; Hibberd PL; Goldin B; Thorpe C; McDermott L; Snydman DR
    Antimicrob Agents Chemother; 2015 Aug; 59(8):4593-9. PubMed ID: 26014940
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A randomized controlled trial of Lactobacillus GG in children with functional abdominal pain.
    Francavilla R; Miniello V; Magistà AM; De Canio A; Bucci N; Gagliardi F; Lionetti E; Castellaneta S; Polimeno L; Peccarisi L; Indrio F; Cavallo L
    Pediatrics; 2010 Dec; 126(6):e1445-52. PubMed ID: 21078735
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of a multi-strain probiotic on the resistance toward Escherichia coli challenge in a randomized, placebo-controlled, double-blind intervention study.
    Ten Bruggencate SJ; Girard SA; Floris-Vollenbroek EG; Bhardwaj R; Tompkins TA
    Eur J Clin Nutr; 2015 Mar; 69(3):385-91. PubMed ID: 25369827
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of efficacy and safety of Lactobacillus rhamnosus in children aged 4-48 months with atopic dermatitis: An 8-week, double-blind, randomized, placebo-controlled study.
    Wu YJ; Wu WF; Hung CW; Ku MS; Liao PF; Sun HL; Lu KH; Sheu JN; Lue KH
    J Microbiol Immunol Infect; 2017 Oct; 50(5):684-692. PubMed ID: 26733351
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ehealth: low FODMAP diet vs Lactobacillus rhamnosus GG in irritable bowel syndrome.
    Pedersen N; Andersen NN; Végh Z; Jensen L; Ankersen DV; Felding M; Simonsen MH; Burisch J; Munkholm P
    World J Gastroenterol; 2014 Nov; 20(43):16215-26. PubMed ID: 25473176
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute Effects of a Glucagon-Like Peptide 2 Analogue, Teduglutide, on Gastrointestinal Motor Function and Permeability in Adult Patients With Short Bowel Syndrome on Home Parenteral Nutrition.
    Iturrino J; Camilleri M; Acosta A; O'Neill J; Burton D; Edakkanambeth Varayil J; Carlson PJ; Zinsmeister AR; Hurt R
    JPEN J Parenter Enteral Nutr; 2016 Nov; 40(8):1089-1095. PubMed ID: 26223941
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Growth during the first 6 months of life in infants using formula enriched with Lactobacillus rhamnosus GG: double-blind, randomized trial.
    Vendt N; Grünberg H; Tuure T; Malminiemi O; Wuolijoki E; Tillmann V; Sepp E; Korpela R
    J Hum Nutr Diet; 2006 Feb; 19(1):51-8. PubMed ID: 16448475
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A double-blind placebo-controlled randomized trial on probiotics in small bowel bacterial overgrowth in children treated with omeprazole.
    Hegar B; Hutapea EI; Advani N; Vandenplas Y
    J Pediatr (Rio J); 2013; 89(4):381-7. PubMed ID: 23796359
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of Lactobacillus casei rhamnosus (LGG) therapy in children with biliary atresia - Randomized placebo controlled trial.
    Orłowska E; Czubkowski P; Wołochowska K; Jarzębicka D; Motyl I; Socha P
    Clin Res Hepatol Gastroenterol; 2021 Nov; 45(6):101753. PubMed ID: 34311135
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bovine colostrum to children with short bowel syndrome: a randomized, double-blind, crossover pilot study.
    Aunsholt L; Jeppesen PB; Lund P; Sangild PT; Ifaoui IB; Qvist N; Husby S
    JPEN J Parenter Enteral Nutr; 2014 Jan; 38(1):99-106. PubMed ID: 23264167
    [TBL] [Abstract][Full Text] [Related]  

  • 18. No Effect of Lactobacillus rhamnosus GG on Eradication of Colonization by Vancomycin-Resistant Enterococcus faecium or Microbiome Diversity in Hospitalized Adult Patients.
    Rubin IMC; Mollerup S; Broholm C; Knudsen SB; Baker A; Helms M; Holm MKA; Kallemose T; Westh H; Dahl Knudsen J; Pinholt M; Petersen AM
    Microbiol Spectr; 2022 Jun; 10(3):e0234821. PubMed ID: 35475684
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Infant behavioral state and stool microbiome in infants receiving Lactocaseibacillus rhamnosus GG in formula: randomized controlled trial.
    Shulman RJ; Chichlowski M; Orozco FG; Harris CL; Wampler JL; Bokulich NA; Berseth CL
    BMC Pediatr; 2022 Oct; 22(1):580. PubMed ID: 36207675
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A randomized, double-blind trial of Lactobacillus GG versus placebo in addition to standard maintenance therapy for children with Crohn's disease.
    Bousvaros A; Guandalini S; Baldassano RN; Botelho C; Evans J; Ferry GD; Goldin B; Hartigan L; Kugathasan S; Levy J; Murray KF; Oliva-Hemker M; Rosh JR; Tolia V; Zholudev A; Vanderhoof JA; Hibberd PL
    Inflamm Bowel Dis; 2005 Sep; 11(9):833-9. PubMed ID: 16116318
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.